Nine Monthly Results Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 37.32% vs 35.46% in Dec 2024
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 148.11% vs -52.89% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 20.00% vs 24.10% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 214.10% vs -38.10% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Astrazeneca Phar With
Figures in Cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
1,696.97
2,543.82
-846.85
-33.29%
Other Operating Income
0.00
53.31
-53.31
-100.00%
Total Operating income
1,696.97
2,597.13
-900.16
-34.66%
Raw Material Cost
9.49
1,109.28
-1,099.79
-99.14%
Purchase of Finished goods
1,547.11
0.00
1,547.11
(Increase) / Decrease In Stocks
-570.31
12.05
-582.36
-4,832.86%
Employee Cost
218.68
315.72
-97.04
-30.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
85.87
0.00
85.87
Other Expenses
205.01
610.75
-405.74
-66.43%
Total Expenditure (Excl Depreciation)
1,495.85
2,047.80
-551.95
-26.95%
Operating Profit (PBDIT) excl Other Income
201.12
549.33
-348.21
-63.39%
Other Income
22.54
33.12
-10.58
-31.94%
Operating Profit (PBDIT)
223.66
582.45
-358.79
-61.60%
Interest
2.45
45.73
-43.28
-94.64%
Exceptional Items
-4.17
-12.16
7.99
65.71%
Gross Profit (PBDT)
217.04
524.56
-307.52
-58.62%
Depreciation
22.98
120.84
-97.86
-80.98%
Profit Before Tax
194.06
403.73
-209.67
-51.93%
Tax
51.42
102.06
-50.64
-49.62%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
142.64
301.68
-159.04
-52.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
142.64
301.68
-159.04
-52.72%
Equity Capital
5.00
24.27
-19.27
-79.40%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
11.85%
21.15%
0.00
-9.30%
Gross Profit Margin
12.79%
20.20%
0.00
-7.41%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,696.97 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 37.32% vs 35.46% in Dec 2024
Nine Monthly - Standalone Net Profit
Standalone Net Profit 142.64 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 148.11% vs -52.89% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 201.12 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 20.00% vs 24.10% in Dec 2024
Nine Monthly - Interest
Interest 2.45 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 214.10% vs -38.10% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.85%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
